We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Reusable Mattress Warmer Treats Neonatal Hypothermia

By HospiMedica International staff writers
Posted on 18 May 2021
Print article
Image: The 12 phase change material “candles” that maintain Dream Warmer temperatures (Photo courtesy of PureTemp)
Image: The 12 phase change material “candles” that maintain Dream Warmer temperatures (Photo courtesy of PureTemp)
A low-cost, non-electric, reusable infant mattress based on the concept of a heating pad can help prevent and treat hypothermia in newborns, according to a new study.

The Dream Warmer, developed by researchers at Partners In Health/Inshuti Mu Buzima (PIH/IMB; Kigali, Rwanda), Boston Children’s Hospital (BCH; MA, USA), and other institutions, is based on a mattress containing 12 phase change material “candles” designed by PureTemp (Minneapolis, MN, USA) that melt to skin temperature and remain so for up to six hours. Once cooled down, the mattress can be cleaned and reused multiple times. It was specifically designed to complement skin-to-skin care (SSC) kangaroo mother care (KMC), either when it provides insufficient heat or if the mother needs to take a break.

To test the mattress, the researchers conducted a cluster-randomized stepped-wedge trial to assess its effect on euthermia and mortality, compared to standard of care in rural Rwandan hospitals. Ten district hospitals enrolled 464 unique infants who used the warmer 892 times. The results showed euthermia rates rose from 51% to 67%; among the encounters in which the warmer was used, only 11% remained hypothermic. Mortality rate among those who used the warmer (0.9%) were also significantly lower than among those who did not (2.8%). The study was published on April 16, 2021, in eClinicalMedicine.

“Infant hypothermia is a silent killer, but it's a modifiable risk factor, and this study shows that reducing it can have a large impact on survival and also likely on the long-term neurodevelopment of these babies,” said senior author Anne Hansen, MD, MPH, of BCH. “This is a good option for treatment in setting where incubators are not the right solution, whether it is because they are too expensive, require electricity, or require extensive training to correctly use and maintain.”

KMC was introduced in 1978 by Edgar Rey Sanabria, MD, in Bogotá (Colombia) as an alternative to incubators for low birth weight infants. KMC has four components: early, continuous, and prolonged SSC between the newborn and mother; exclusive breastfeeding; early discharge from the health facility; and close follow-up at home. It is thought to improve neonatal outcomes by maintaining infant temperature through SSC and by providing the benefits of breastfeeding, which are beneficial for all newborns, but may be especially advantageous for preterm infants.

Related Links:
Partners In Health/Inshuti Mu Buzima
Boston Children’s Hospital
PureTemp


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.